Treace Medical Concepts, Inc. (TMCI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 155.01M |
| Enterprise Value | 158.28M |
| P/E Ratio | -6.22 |
| PEG Ratio | 0.59 |
| Price/Sales Ratio | 1.73 |
| Price/Book Ratio | 5.68 |
| Enterprise/Revenue | 2.06 |
| Enterprise/EBITDA | -9.48 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.27 |
| Operating Margin | -0.24 |
| Return On Assets | -0.31 |
| Return On Equity | -0.76 |
| Revenue | 212.69M |
| Revenue/Share | 3.11 |
| Gross Profit | 169.75M |
| EBITDA | -43.18M |
| Net Income | -59M |
| Diluted EPS | -0.93 |
| Total Cash | 39.8M |
| Total Cash/Share | 0.61 |
| Total Debt | 74.85M |
| Total Debt/Equity | 1.21 |
| Current Ratio | 2.58 |
| Book Value Per Share | 0.94 |
| 52-Week Change | 60.68 |
| 52-Week High | 5.44 |
| 52-Week Low | 1.17 |
| Moving Average 50 Days | 4.41 |
| Moving Average 200 Days | 3.31 |
| Average Volume | 275,164 |
| Shares Outstanding | 65.56M |
| % Held by Institutions | 49.41 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |